306 related articles for article (PubMed ID: 24264239)
1. Biology of human pathogenic trypanosomatids: epidemiology, lifecycle and ultrastructure.
Rodrigues JC; Godinho JL; de Souza W
Subcell Biochem; 2014; 74():1-42. PubMed ID: 24264239
[TBL] [Abstract][Full Text] [Related]
2. Serodiagnosis of leishmaniasis.
Kar K
Crit Rev Microbiol; 1995; 21(2):123-52. PubMed ID: 7639932
[TBL] [Abstract][Full Text] [Related]
3. Determinants of disease phenotype in trypanosomatid parasites.
McCall LI; McKerrow JH
Trends Parasitol; 2014 Jul; 30(7):342-9. PubMed ID: 24946952
[TBL] [Abstract][Full Text] [Related]
4. Escaping Deleterious Immune Response in Their Hosts: Lessons from Trypanosomatids.
Geiger A; Bossard G; Sereno D; Pissarra J; Lemesre JL; Vincendeau P; Holzmuller P
Front Immunol; 2016; 7():212. PubMed ID: 27303406
[TBL] [Abstract][Full Text] [Related]
5. Targeting calcium homeostasis as the therapy of Chagas' disease and leishmaniasis - a review.
Benaim B; Garcia CR
Trop Biomed; 2011 Dec; 28(3):471-81. PubMed ID: 22433874
[TBL] [Abstract][Full Text] [Related]
6. Basic Biology of Trypanosoma cruzi.
Zuma AA; Dos Santos Barrias E; de Souza W
Curr Pharm Des; 2021; 27(14):1671-1732. PubMed ID: 33272165
[TBL] [Abstract][Full Text] [Related]
7. Ornithine decarboxylase and S-adenosylmethionine decarboxylase in trypanosomatids.
Persson L
Biochem Soc Trans; 2007 Apr; 35(Pt 2):314-7. PubMed ID: 17371268
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of glycosomal protein import provide new leads against trypanosomiasis.
Kalel VC; Emmanouilidis L; Dawidowski M; Schliebs W; Sattler M; Popowicz GM; Erdmann R
Microb Cell; 2017 Jul; 4(7):229-232. PubMed ID: 28706938
[TBL] [Abstract][Full Text] [Related]
9. Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis.
Heby O; Persson L; Rentala M
Amino Acids; 2007 Aug; 33(2):359-66. PubMed ID: 17610127
[TBL] [Abstract][Full Text] [Related]
10. From the cell biology to the development of new chemotherapeutic approaches against trypanosomatids: dreams and reality.
De Souza W
Kinetoplastid Biol Dis; 2002 May; 1(1):3. PubMed ID: 12234386
[TBL] [Abstract][Full Text] [Related]
11. Parasite prolyl oligopeptidases and the challenge of designing chemotherapeuticals for Chagas disease, leishmaniasis and African trypanosomiasis.
Bastos IM; Motta FN; Grellier P; Santana JM
Curr Med Chem; 2013; 20(25):3103-15. PubMed ID: 23514419
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Strategies against
Santos ALS; Rodrigues IA; d'Avila-Levy CM; Sodré CL; Ritmeijer K; Branquinha MH
Pathogens; 2023 Oct; 12(10):. PubMed ID: 37887779
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous leishmaniasis in Egypt (review and comment).
Morsy TA
J Egypt Soc Parasitol; 1996 Apr; 26(1):105-30. PubMed ID: 8721233
[TBL] [Abstract][Full Text] [Related]
14. Iron metabolism in trypanosomatids, and its crucial role in infection.
Taylor MC; Kelly JM
Parasitology; 2010 May; 137(6):899-917. PubMed ID: 20152063
[TBL] [Abstract][Full Text] [Related]
15. [Study of cases of leishmaniasis in the Province of Salta: evidences of mixed infection with Trypanosoma cruzi and Leishmania spp].
Chiaramonte MG; Zwirner NW; Caropresi SL; Heredia V; Taranto NJ; Malchiodi EL
Medicina (B Aires); 1996; 56(3):259-68. PubMed ID: 9035482
[TBL] [Abstract][Full Text] [Related]
16. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
[TBL] [Abstract][Full Text] [Related]
17. [Human African trypanosomiasis].
Dumas M; Bouteille B
C R Seances Soc Biol Fil; 1996; 190(4):395-408. PubMed ID: 8952890
[TBL] [Abstract][Full Text] [Related]
18. Leishmania, Trypanosoma and monoxenous trypanosomatids as emerging opportunistic agents.
Dedet JP; Pratlong F
J Eukaryot Microbiol; 2000; 47(1):37-9. PubMed ID: 10651294
[TBL] [Abstract][Full Text] [Related]
19. Potential Drug Targets in the Pentose Phosphate Pathway of Trypanosomatids.
Loureiro I; Faria J; Santarem N; Smith TK; Tavares J; Cordeiro-da-Silva A
Curr Med Chem; 2018; 25(39):5239-5265. PubMed ID: 29210635
[TBL] [Abstract][Full Text] [Related]
20. Comparative Analysis of Virulence Mechanisms of Trypanosomatids Pathogenic to Humans.
de Castro Neto AL; da Silveira JF; Mortara RA
Front Cell Infect Microbiol; 2021; 11():669079. PubMed ID: 33937106
[No Abstract] [Full Text] [Related]
[Next] [New Search]
